PHASE-II STUDY WITH THE COMBINATION ETOPOSIDE, DOXORUBICIN, AND CISPLATIN IN ADVANCED MEASURABLE GASTRIC-CANCER

被引：296

作者：

PREUSSER, P

WILKE, H

ACHTERRATH, W

FINK, U

LENAZ, L

HEINICKE, A

MEYER, J

MEYER, HJ

BUENTE, H

机构：

[1] UNIV CLIN MUENSTER, DEPT SURG, MED ONCOL SECT, MUNSTER, FED REP GER

[2] UNIV HANOVER, SCH MED, DEPT HEMATOL ONCOL, D-3000 HANOVER, FED REP GER

[3] UNIV HANOVER, SCH MED, DEPT SURG, D-3000 HANOVER, FED REP GER

[4] BRISTOL MYERS CO, ANTICANC RES, NEW YORK, NY USA

[5] TECH UNIV MUNICH, MED CLIN, D-8000 MUNICH 2, FED REP GER

[6] UNIV MUNSTER, INST MED INFORMAT & BIOMATH, D-4400 MUNSTER, FED REP GER

来源：

关键词：

D O I：

10.1200/JCO.1989.7.9.1310

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1310 / 1317

页数：8

共 72 条

[1] ETOPOSIDE - CHEMISTRY, PRE-CLINICAL AND CLINICAL-PHARMACOLOGY
ACHTERRATH, W
NIEDERLE, N
RAETTIG, R
HILGARD, P
[J]. CANCER TREATMENT REVIEWS, 1982, 9 : 3 - 13
[2] BEHARS OH, 1983, MANUAL STAGING CANCE, P67
[3] BERETTA G, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P94
[4] BERETTA G, 1982, P AN M AM SOC CLIN, V23, P103
[5] BERETTA G, 1983, P AN M AM SOC CLIN, V2, P131
[6] BERNATH AM, 1979, P AM ASSOC CANC RES, V20, P312
[7] BIRAN H, 1984, P AN M AM SOC CLIN, V3, P132
[8] BORCHARD F, 1985, THERAPIEWOCHE, V35, P161
[9] CARTEI G, 1985, MITOMYCIN 85 AKTUELL, P56
[10] CAZAP EL, 1986, CANCER TREAT REP, V70, P781